Safety Study of Allogeneic Mesenchymal Precursor Cells (MPCs) in Subjects With Recent Acute Myocardial Infarction
Conditions
Interventions
- GENETIC: Allogeneic Mesenchymal Precursor Cells (MPCs)
- PROCEDURE: Standard-of-care treatment with NOGA® mapping and staged injections.
- GENETIC: Allogeneic Mesenchymal Precursor Cells (MPCs)
- PROCEDURE: Standard-of-care treatment with NOGA® mapping and staged injections.
- GENETIC: Allogeneic Mesenchymal Precursor Cells (MPCs)
- PROCEDURE: Standard-of-care treatment with NOGA® mapping and staged injections.
Sponsor
Angioblast Systems